- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02886780
"Concentrated Exposure Treatment" (cET) for for Obsessive Compulsive Disorder
February 10, 2021 updated by: Haukeland University Hospital
Concentrated Exposure Treatment (cET) for Obsessive Compulsive Disorder (OCD). A Randomized Controlled Trial (RCT)
Obsessive Compulsive Disorder (OCD) often becomes chronic if not treated.
Exposure and response prevention (ERP) is recommended psychological treatment.
The OCD-team at Haukeland University hospital has developed a concentrated 4-day treatment format which has been evaluated as part of standard care.
Next step in the methodological development is to conduct a randomized controlled trial where the 4-day format is compared to self-help and waiting list.
The study will be conducted at Solvang DPS, Sørlandet Hospital.
Participants (16 in each group) are ordinary patients (>18 yrs) entitled to care in the specialist health care.
Study Overview
Status
Active, not recruiting
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Anticipated)
48
Phase
- Not Applicable
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
16 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
OCD-patients referred to the OCD-team at Sørlandet Sykehus, Solvang DPS will be included.
Inclusion criteria
- Outpatients
- ≥ 18 years of age
- Fulfilling diagnostic criteria of OCD according to the DSM-5
- Y-BOCS ≥ 16
- Fluent in Norwegian
- Signed informed consent
Exclusion Criteria:
- OCD symptoms primarily associated with hoarding
- Ongoing substance abuse/dependence
- Bipolar disorder or psychosis
- Ongoing suicidal ideation
- Mental Retardation, based on previous medical history
If using antidepressants:
- Not on stable dosage 4 weeks before the intervention
- Unwilling to remain on stable dosage during the four intervention days
- Unwilling to refrain from anxiety reducing substances, such as anxiolytics (e.g. benzodiazepines) and alcohol during the two days of exposure.
- Patients living > 1.5 hour drive by car/ train from the treatment location.
- Patients with a BMI-index considered too low for participation in psychological treatment
- Patients with a full course of prior CBT for OCD.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
No Intervention: Wait list
|
|
Experimental: Concentrated Exposure Treatment (cET)
Please refer to:Havnen, A., Hansen, B., Öst, L.-G. & Kvale, G. Concentrated ERP delivered in a group setting: An effectiveness study.
Journal of Obsessive Compulsive and Related Disorders 3, 319-324 (2014)
|
Psychological cognitive behavioral treatment
|
Active Comparator: Self-help
The self-help condition (SH): Foa, E.B. & Kozak, M.J. Mastery of obsessive-compulsive disorder: Client workbook, (Graywind Publications, New York, 1997). |
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Changes in Y-BOCS from pre cET-treatment to post treatment/ waiting list/ self-help
Time Frame: Pre-treatment, 1 week post, minimum nine weeks after pre-treatment, minimum six months follow up
|
Y-BOCS changes will for all conditions be calculated by two approaches which will be compared.
|
Pre-treatment, 1 week post, minimum nine weeks after pre-treatment, minimum six months follow up
|
Changes i OCD diagnostic status (DSM-5) as measured by SCID
Time Frame: Pre-treatment, 1 week post, minimum nine weeks after pre-treatment, minimum six months follow up
|
Pre-treatment, 1 week post, minimum nine weeks after pre-treatment, minimum six months follow up
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Well-being
Time Frame: Pre-treatment, 1 week post, minimum nine weeks after pre-treatment, minimum six months follow up
|
The Warwick-Edinburgh Mental Well-being Scale (WEMWBS) will be administered to assess mental well-being.
This scale has 14 items covering different aspects of mental health related to mental well-being.
|
Pre-treatment, 1 week post, minimum nine weeks after pre-treatment, minimum six months follow up
|
Work and social adjustment
Time Frame: Pre-treatment, 1 week post, minimum nine weeks after pre-treatment, minimum six months follow up
|
The Work and Social Adjustment Scale (W & SAS) is a short questionnaire measuring work and social adjustment.
|
Pre-treatment, 1 week post, minimum nine weeks after pre-treatment, minimum six months follow up
|
Generalized anxiety
Time Frame: Pre-treatment, 1 week post, minimum nine weeks after pre-treatment, minimum six months follow up
|
Generalized Anxiety Disorder Assessment 7 (GAD-7) is a brief 7-item self-report measure for generalized anxiety symptoms.
Although developed for measuring severity of generalized anxiety disorder, the GAD-7 measures severity of general anxiety symptoms common to several anxiety disorders
|
Pre-treatment, 1 week post, minimum nine weeks after pre-treatment, minimum six months follow up
|
Depression
Time Frame: Pre-treatment, 1 week post, minimum nine weeks after pre-treatment, minimum six months follow up
|
Patient Health Questionnaire, (PHQ-9) is a 9-item self-report questionnaire measuring level of depressive symptoms.
Items are scored on a scale from 0 (not at all) to 3 (nearly every day).
|
Pre-treatment, 1 week post, minimum nine weeks after pre-treatment, minimum six months follow up
|
Insomnia
Time Frame: Pre-treatment, 1 week post, minimum nine weeks after pre-treatment, six months follow up
|
The Bergen Insomnia Scale (BIS) will be used to screen for sleep disturbances.
The scale has six items covering different aspects of sleep disturbances the past 4 weeks
|
Pre-treatment, 1 week post, minimum nine weeks after pre-treatment, six months follow up
|
Client satisfaction
Time Frame: 1 week post Concentrated Exposure Treatment
|
Client Satisfaction Questionnaire (CSQ-8) is an eight-item self-report form where patients report their level of satisfaction with the treatment they have undergone.
|
1 week post Concentrated Exposure Treatment
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Principal Investigator: Gerd Kvale, PhD, Haukeland UH
- Study Chair: Gunvor Launes, MD, Sorlandet Hospital HF
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
September 1, 2016
Primary Completion (Actual)
June 1, 2018
Study Completion (Anticipated)
June 1, 2023
Study Registration Dates
First Submitted
August 29, 2016
First Submitted That Met QC Criteria
August 31, 2016
First Posted (Estimate)
September 1, 2016
Study Record Updates
Last Update Posted (Actual)
February 11, 2021
Last Update Submitted That Met QC Criteria
February 10, 2021
Last Verified
February 1, 2020
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2016/794 (REK vest)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Undecided
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Obsessive Compulsive Disorder (OCD)
-
Icahn School of Medicine at Mount SinaiNational Institute of Mental Health (NIMH)RecruitingObsessive Compulsive Disorder (OCD)United States
-
University of ArizonaActive, not recruitingObsessive-compulsive Disorder (OCD)United States
-
University of LeipzigGerman Research Foundation; Philipps University Marburg Medical CenterCompleted
-
New York State Psychiatric InstituteCompletedObsessive-Compulsive Disorder (OCD)United States
-
Baylor College of MedicineBrown University; Duke University; University of Washington; Mclean Hospital; William... and other collaboratorsNot yet recruitingObsessive-Compulsive Disorder (OCD)United States
-
New York State Psychiatric InstituteCompletedObsessive Compulsive Disorder (OCD)United States
-
The University of Texas Health Science Center,...MedtronicRecruitingObsessive-Compulsive Disorder (OCD)United States
-
University of BathSouth London and Maudsley NHS Foundation Trust; Avon and Wiltshire Mental Health...UnknownObsessive Compulsive Disorder (OCD)United Kingdom
-
Assistance Publique - Hôpitaux de ParisRecruitingObsessive Compulsive Disorder OCDFrance
-
Xuanwu Hospital, BeijingNot yet recruiting
Clinical Trials on Concentrated exposure treatment (cET)
-
Haukeland University HospitalUniversity of BergenRecruiting
-
University of California, San DiegoNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); National...Completed
-
Kessler FoundationUnknownBreast CancerUnited States
-
Virginia Polytechnic Institute and State UniversityNational Institute of Mental Health (NIMH)CompletedAnxiety Disorders | Specific PhobiaUnited States
-
University of BarcelonaNot yet recruitingAnxiety | Randomized Controlled Trial | Virtual Reality Exposure Therapy | AerophobiaSpain
-
University of PittsburghNational Institute on Drug Abuse (NIDA)CompletedSchizophrenia | Schizoaffective DisorderUnited States
-
Karolinska InstitutetRegion StockholmRecruitingPost Traumatic Stress DisorderSweden
-
Leiden UniversityRadboud University Medical Center; ZonMw: The Netherlands Organisation for... and other collaboratorsCompletedPost Traumatic Stress DisorderNetherlands
-
Office of Naval Research (ONR)United States Naval Medical Center, San Diego; Naval Hospital Camp Pendleton; Virtual Reality Medical CenterCompletedPost-Traumatic Stress DisorderUnited States
-
Stanford UniversityKarolinska Institutet; National Institute of Arthritis and Musculoskeletal...RecruitingChronic Pain | Child Behavior | Adolescent Behavior | ExposureUnited States